CLDT

Don't be fooled by the headline 93x P/E: CLDT is a hotel REIT, where depreciation ($59.7M of D&A on $295M revenue) crushes GAAP EPS while cash flow tells the real story. Adding D&A back to the $15.1M of net income implies roughly $75M of FFO, or about $1.58/share — putting the stock near ~8x FFO, a normal-to-slightly-cheap multiple for lodging. More striking, book equity of $741M on 47.3M shares is about $15.66/share, so at $13.04 the stock trades at roughly 0.83x book. The balance sheet backs that value up: liabilities/equity of just 0.53x, long-term debt down 16.7% to $339M, and cash up 21%. This is a conservatively financed, deleveraging REIT trading below its own accounting equity.

The catch is that the business is shrinking, not compounding. Revenue fell 7% because management sold seven hotels (Denver, Maitland, Bloomington, Brentwood, two in Houston, Billerica) against one Phoenix acquisition — deliberate capital recycling, not collapse. But the MD&A concedes same-property RevPAR was down 0.1%, i.e. essentially flat: there is no organic demand tailwind here, and room revenue (the core) dropped 7.3%. The 261% net-income jump is largely optics off a tiny base and asset-sale gains, not a durable earnings engine — ROE is a thin 2.0%. So the 'growth' story is really a value story: a portfolio of upscale extended-stay hotels (33 hotels, 5,021 rooms, heavy Silicon Valley/California weighting) being run for cash, buying back $9.0M of stock below book and paying a ~$0.37/share dividend.